19.4 Multi-Code-Set Diagnostic and Interventional Cases

19.4 Multi-Code-Set Diagnostic and Interventional Cases

Quick Answer: Mixed records fail candidates who pick a CPT in isolation. Decide the indication first (screening versus diagnostic), then the procedure actually performed, then HCPCS (Medicare screening G-codes, modifier PT, drug units). Surgical endoscopy includes diagnostic endoscopy of the same structure. Section IV.Q / I.C.21 keep a screening Z code first-listed when the encounter is a screening, even if a polyp is found; a symptom such as hematochezia means the test was never a screening.

This is the last Cases-domain pattern: radiology plus medicine plus surgery on one note, or a screening G-code that must be abandoned mid-procedure. The seven-step workflow does not change. What changes is that first-listed diagnosis and the CPT family can look as if they disagree unless you sequence them on purpose.

Indication drives both ICD-10-CM and the CPT/HCPCS family

Screening means testing a seemingly well person. If the history documents rectal bleeding, a positive fecal occult blood test being evaluated, or iron-deficiency anemia as the reason for the colonoscopy, the indication is diagnostic even if the scheduler titled the slot 'screening.' That is a Z-code chapter rule applied to a CPT family: wrong indication → wrong first-listed code and wrong HCPCS/CPT.

Medicare screening without therapy stays on G0105 or G0121. When a screening exam becomes biopsy or polypectomy, you replace the G-code with the surgical endoscopy CPT and append PT (colorectal cancer screening test; converted to diagnostic test or other procedure) to each converted CPT line. Do not report G0121 and 45385. Commercial payers may want modifier 33 on a preventive service; PT is the Medicare conversion modifier taught with digestive endoscopy.

Keep Z12.11 first-listed for a true screening that finds a polyp. The adenoma does not steal first-listed position just because it required a snare. The screening is still the reason the seemingly well patient came; the polyp is an additional finding.

Endoscopy bundling you must see in a mixed case

Surgical endoscopy includes diagnostic endoscopy of the same structure. That is why:

• 43239 (EGD with biopsy) is reported alone, not with 43235
• 45385 (colonoscopy with snare) is reported without leftover 45378
• 45380 is a single-or-multiple biopsy family — one 45380 even when several jars go to pathology

A different technique on a different lesion can be separately reportable: snare of a transverse adenoma (45385) plus cold biopsy of a separate sigmoid lesion (45380) may both be reported, with a distinct-service modifier (59 or XS when the distinct site is the point, per MLN1783722) when the hospital PTP file is CCMI 1 and the note supports two lesions and two techniques. Do not append 59 merely because two descriptors differ.

Incomplete colonoscopy and facility 73/74 versus professional 53 were taught in digestive endoscopy. On a Cases item, read whether the scope reached the cecum and whether anesthesia had started. Do not drop professional 53 onto the facility line as a habit.

Interventional and radiology add-ons that are already in the CPT

Many 2026 pain and interventional codes include imaging guidance. 62323 (lumbar or sacral interlaminar epidural injection with imaging guidance — fluoroscopy or CT) already includes 77003. Adding 77003 is unbundling. The steroid is a HCPCS problem, not a second CPT: J3301 is triamcinolone acetonide per 10 mg, so 40 mg is 4 units. Expect SI N packaging unless Addendum B shows a separately payable assignment above the $140 per-day threshold — typical triamcinolone doses are not separately payable OPPS drugs.

Section IV.K for a stand-alone interpreted diagnostic test: if the radiologist's final report confirms a disease, code that disease, not the symptom that prompted the test as an extra code on a diagnostic-only encounter. That differs from an ED visit whose reason remains the injury even when CT is negative.

Moderate sedation, when not inherent, has its own medicine-section family. If the CPT descriptor already includes sedation, do not add 99152. Read the parenthetical.

Worked case MULTI-1 (synthetic, de-identified)

Lakeside Hospital Endoscopy — on-campus HOPD, POS 22, Medicare, type of bill 131 Date: 8 June 2026.

Excerpt:

67-year-old, average risk, no gastrointestinal symptoms, referred for colorectal cancer screening. Bowel preparation adequate. Colonoscope advanced to the cecum and into the terminal ileum. 8 mm sessile polyp in the transverse colon removed with snare and retrieved. 3 mm sigmoid polyp removed with cold biopsy forceps. No other lesions. Pathology (available at coding): tubular adenoma, transverse colon; hyperplastic polyp, sigmoid colon. Anesthesia: propofol. No perforation. Discharged home.

Coding rationale — MULTI-1

Trap case MULTI-2 (synthetic, shorter) — bundled EGD plus a fake screening

Two stems, one lesson.

Stem A. EGD for heartburn. Biopsies of the gastric antrum. The coder reports 43235 and 43239 because 'we looked and we biopsied.'

Correct: 43239 only. Surgical EGD includes diagnostic EGD.

Stem B. The order sheet says 'screening colonoscopy.' The HPI documents hematochezia for three weeks. Colonoscope to cecum, no therapy.

Wrong path: G0121 with Z12.11 because the title said screening; or 45378-PT to 'split the difference.'

Correct path: This was never a screening of a seemingly well person. Report 45378 (diagnostic colonoscopy) and first-list the bleeding code the record supports (for example K92.1 melena or K62.5 hemorrhage of anus and rectum, after Index/Tabular confirmation). No G0121, no PT, no Z12.11 as a screening reason. PT is for a converted screening, not for a diagnostic exam that was mislabeled in the schedule.

Trap case MULTI-3 (synthetic, shorter) — included fluoroscopy and a packaged steroid

Cedar Fork Pain Clinic, hospital outpatient, Medicare. Lumbar interlaminar epidural steroid injection under fluoroscopy for lumbar radiculopathy. Triamcinolone 40 mg injected. The coder adds 77003 and bills J3301 as a separately payable SI K drug 'because J-codes always pay.'

Correct path: 62323 includes imaging guidance. Do not add 77003. First-listed M54.16 when that is the documented indication. J3301 × 4 units (10 mg descriptor × 4 = 40 mg). Expect packaging under the CY 2026 $140 threshold (SI N) unless Addendum B shows a rare separately payable assignment. JW/JZ still do not apply to SI N packaged drugs.

Putting the whole Cases domain together

On exam day the 10 cases will not be labeled 'SDS,' 'ED,' 'observation,' or 'endoscopy.' You supply the label by reading the header. Then you run the same seven steps:

1. Header / POS / anesthesia times
2. Section IV first-listed (surgery reason, observation condition, screening Z code, or ED symptom — and never uncertain language as confirmed disease)
3. Procedures actually performed, including bundled endoscopy and included guidance
4. HCPCS units, G0463 vs ED CPT vs G0378 vs screening G-codes vs PT
5. Hospital NCCI, 25 vs 59/X, 73 vs 74 vs 53
6. OPPS J1 / J2 / T / V / N / K / G and the $140 drug threshold
7. If it is not in the record, it is not the answer

That method is the Cases domain. The books supply the codes. The record supplies the facts. Your job is to refuse every code the facts do not support.